Navigation Links
Hopkins researchers discover how brain protein might control memory

Researchers at Johns Hopkins have figured out how one particular protein contributes to long-term memory and helps the brain remember things longer than an hour or two. The findings are reported in two papers in the Nov. 9 issue of Neuron.

The protein, called Arc, has been implicated in memory-linked behaviors ranging from song learning in birds to rodents being aware of 3-D space. In people, Arc may be one culprit behind certain long-term memory-based behaviors like drug addiction, the researchers say.

"We think Arc controls how brain cells learn and associate behaviors and remember them over a long period of time," says Paul F. Worley, M.D., professor of neuroscience and neurology at Hopkins and director of both studies. "For example, the person who quits smoking can wean himself from cravings at home, at work or outside. But if you put him in a bar with a drink in his hand, his brain remembers that former association and suddenly the craving returns. These types of long-term associations are memories wired in your brain."

Years ago, Worley and his colleagues, studying laboratory rats, found that their brains made lots of Arc protein while the animals were awake and active. In fact, it has been long known that stimulating individual nerve cells - by an act as simple as exploring new environs, for example - causes the cells to make more Arc protein almost immediately. "Arc is an instant and reliable readout for active cells in the brain," says Worley. But although scientists knew that active cells were making copious amounts of Arc, no one knew exactly what Arc was doing in those cells until now.

To figure out what Arc was doing, the Hopkins team looked for what other proteins Arc "plays" with. Using Arc protein as bait, they went on a molecular fishing expedition in a pond filled with other proteins normally found in the brain and hooked two known to be involved in transporting materials into and out of cells.

"Mov
'"/>

Source:Johns Hopkins Medical Institutions


Page: 1 2 3

Related biology news :

1. Hopkins AIDS experts issue warning about global efforts to provide drug therapies
2. Hopkins scientists uncover tags that force proteins to cell surface
3. Johns Hopkins flu expert calls for mandatory vaccination of health care workers
4. Whole-genome study at Johns Hopkins reveals a new gene associated with abnormal heart rhythm
5. Hopkins researchers discover genetic switch that turns off an oxygen-poor cells combustion engine
6. Hopkins study suggests commercially available antibiotic may help fight dementia in HIV patients
7. Johns Hopkins lab scientists tame overactive CF protein
8. Hopkins researchers develop new tool to watch real-time chemical activity in cells
9. Hopkins scientists show hallucinogen in mushrooms creates universal mystical experience
10. Hopkins scientists link immune response to ghost parasites and severely congested sinuses
11. NYU researchers simulate molecular biological clock
Post Your Comments:
(Date:8/20/2008)...nta, Ga. August 20, 2008) Today, the U.S. Environ... of a $2 million grant to the University of Kentuc... nanoparticles affect their ability to enter the b...Results (STAR) grant ever awarded to the Universit...ever awarded by EPA STAR for nanotechnology resear...
(Date:8/20/2008)...AKERS are supposed to protect people from heart at... as well as biological security. , Earlier this y...al School demonstrated how a commercial radio tran...tions from a pacemaker ( New Scientist, 22 March,...tor and adjust the implanted device, but a malicio...
(Date:8/20/2008)...entre for Addiction and Mental Health (CAMH) is pr...on by the Canada Foundation for Innovation (CFI) i...ntervention, treatment and prevention of mental il...e. , This funding from the Large-Scale Institut...tal Fund will allow CAMH to leverage our scientifi...
(Date:8/20/2008)...COLUMBUS, Ohio -- Researchers here have found a wa...gen very efficiently. , A new catalyst makes hyd...kable temperature, and using inexpensive ingredien...olecular engineering at Ohio State University, sai...n others being developed around the world, because...
Breaking Biology News(10 mins):$2M grant awarded to University of Kentucky for research on nanoparticles and human health 2How to stop a new type of heart attack 2Large-scale investment catapults CAMH's mental illness and addiction research forward 2A better way to make hydrogen from biofuels 2A better way to make hydrogen from biofuels 3Susan G Komen For The Cure Karmanos Cancer Institute Local Hospitals Call on Policymakers to Address Injustice and Unfairness in Breast Cancer Inci 4421 1Susan G Komen For The Cure Karmanos Cancer Institute Local Hospitals Call on Policymakers to Address Injustice and Unfairness in Breast Cancer Inci 4421 2Susan G Komen For The Cure Karmanos Cancer Institute Local Hospitals Call on Policymakers to Address Injustice and Unfairness in Breast Cancer Inci 4421 3Susan G Komen For The Cure Karmanos Cancer Institute Local Hospitals Call on Policymakers to Address Injustice and Unfairness in Breast Cancer Inci 4421 4Oncolytics Biotech Inc Announces Approval for U K Clinical Trial Investigating REOLYSIN 28R 29 in Combination with Cyclophosphamide 1450 1Oncolytics Biotech Inc Announces Approval for U K Clinical Trial Investigating REOLYSIN 28R 29 in Combination with Cyclophosphamide 1450 2Oncolytics Biotech Inc Announces Approval for U K Clinical Trial Investigating REOLYSIN 28R 29 in Combination with Cyclophosphamide 1450 3Cephalon Announces Positive Results from Its Pivotal Study of TREANDA in Patients with Non Hodgkins Lymphoma 621 1Cephalon Announces Positive Results from Its Pivotal Study of TREANDA in Patients with Non Hodgkins Lymphoma 621 2Cephalon Announces Positive Results from Its Pivotal Study of TREANDA in Patients with Non Hodgkins Lymphoma 621 3Cephalon Announces Positive Results from Its Pivotal Study of TREANDA in Patients with Non Hodgkins Lymphoma 621 4Tracleer 28R 29 Shows Clinical Benefit as Combination Therapy with Sildenafil for Pulmonary Arterial Hypertension 619 1Tracleer 28R 29 Shows Clinical Benefit as Combination Therapy with Sildenafil for Pulmonary Arterial Hypertension 619 2Tracleer 28R 29 Shows Clinical Benefit as Combination Therapy with Sildenafil for Pulmonary Arterial Hypertension 619 3
...stration (FDA) today announced a series of importa...steroidal anti-inflammatory class of drugs, includ...ription (over-the-counter (OTC)) non-selective NSA...ble on the Internet at http://www.fda.gov/cder/dru...otect and advance the health of the millions of Am...
...Polytechnique Fédérale de Lausanne (EPFL) in Switz...ce to silence a mutated gene that causes inherited...tantially delaying both the onset and the progress...results will be published in the April issue of Na...e publication March 13. , In addition to silencing...
...stitute researchers chiseling away at the problem ...nation of how the drugs, main cellular target in b...se medications. The findings are already leading t...neered to circumvent resistance, which is a major ...z, a Howard Hughes Medical Institute investigator ...
...first time mapped multiple complex biological inte...m, enhancing our understanding of how the networks...uence one another. New research published in the O...uch maps can also reveal cryptic interactions and ...t haven,t been observed experimentally. , A living...
Other Biology News:FDA Announces Series of Changes to the Class of Marketed Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) 2Silence the gene, save the cell: RNA interference as promising therapy for ALS 2Silence the gene, save the cell: RNA interference as promising therapy for ALS 3Researchers make gains in understanding antibiotic resistance 2Researchers make gains in understanding antibiotic resistance 3Navigating an integrated yeast network 2
(Date:8/21/2008)... NEW YORK, MUNICH, Germany and AMSTERDAM, Neth...thcare and SpePharm Holding, B.V., the,pan-Europea...d that they,have entered into a euro 10 million re...fund SpePharm,s acquisition of Dantrium(R) for Eur...le Pharmaceuticals. At the same,time, TVM Capital,...
(Date:8/20/2008)... VIENNA, Va., Aug. 20 /PRNewswire-USNewswire/ ...0 ranking of the fastest-growing private companies...T) services provider,MicroTech, ranks No. 285 on ... 2008 Inc. 500 list measures revenue growth from 2...U.S.-based, privately held, independent -,no subsi...
(Date:8/20/2008)... INDIANAPOLIS, Ind., Aug. 20 /PRNewswire-First... announced that it has completed the acquisition,o...n Diego-based,biotechnology company focused on dru...y. The completion of the deal followed today,s Spe...SGX stockholders voted in,favor of the merger agre...
(Date:8/20/2008)... Growth Fueled by Popularity with Seniors and ... Marketing, CAMBRIDGE, Mass., Aug. 20 /PRNewswi...hole Health (SWH), a voluntary health care plan fo...ng private company in the,United States., Part of...rowing,companies, SWH had revenue growth of 31,000...
Breaking Biology Technology:TVM Capital, Signet Healthcare Partners and Paul Capital Healthcare Enter into euro 26 Million Financing of SpePharm 2TVM Capital, Signet Healthcare Partners and Paul Capital Healthcare Enter into euro 26 Million Financing of SpePharm 3TVM Capital, Signet Healthcare Partners and Paul Capital Healthcare Enter into euro 26 Million Financing of SpePharm 4TVM Capital, Signet Healthcare Partners and Paul Capital Healthcare Enter into euro 26 Million Financing of SpePharm 5MicroTech Ranks No. 285 on Inc. Magazine's 2008 List of the 500 Fastest Growing Private Companies in America 2Lilly Announces Completion of SGX Acquisition 2Inc. Magazine Names Senior Whole Health the Number One Fastest-Growing Private Company in US 2Inc. Magazine Names Senior Whole Health the Number One Fastest-Growing Private Company in US 3
...d by the Circuit Court of Wisconsin in Milwaukee ...d businesses that acquired Microsoft software ov...ibute nearly $224 million back to them as part of ...against the software giant. , ,The notices are the...awsuits about whether Microsoft violated Wisconsin...
...rs is Japan. In this column, I have covered differ...y and biotech markets (3/10/03, 8/18/03, 3/28/05).... Bio-Jan 2006 Conference in September after a th...rticipate in the 30th anniversary celebration of t...ad started in Chicago and culminated in a series o...
...n will decide whether to change the current long-s... be patentable, an invention must not be "obvious"... it was created by the inventor, and any change in...mpact the ability to procure and enforce patents. ...riefs to appreciate the importance of this case: ...
...ate that the Greater Madison area, while a key U.S...ched the "critical mass" of talent, innovation, an...nts and achieve a state of sustained growth. , ,Bu...convened Tuesday to welcome an emerging drug disco...hern suburb of Madison, a different message emerge...
Other Biology Technology:Microsoft to distribute $224M as part of settlement 2Japan on the rebound: Implications for Midwest 2Japan on the rebound: Implications for Midwest 3Japan on the rebound: Implications for Midwest 4Japan on the rebound: Implications for Midwest 5Japan on the rebound: Implications for Midwest 6Japan on the rebound: Implications for Midwest 7Japan on the rebound: Implications for Midwest 8Japan on the rebound: Implications for Midwest 9Inventions could fall prey to Monday morning quarterbacking 2Inventions could fall prey to Monday morning quarterbacking 3Inventions could fall prey to Monday morning quarterbacking 4Caden Biosciences may signal critical mass 2
Mouse monoclonal antibody raised against a full length recombinant SLC25A11. NCBI Entrez Gene ID = SLC25A11
Mouse monoclonal antibody raised against a partial recombinant TOPORS. Immunogen: TOPORS (NP_005793, 98 a.a. ~ 206 a.a) partial recombinant protein with GST tag. Accession Number: NM_005802
Mouse monoclonal antibody raised against a full length recombinant SNAPC5. NCBI Entrez Gene ID = SNAPC5
...al recombinant NFKBIB. Immunogen: NFKBIB (AAH1...in with GST tag. Protein Sequence: EDGDTALHLAV...GAGLCVAERRGHTALHLACRVGAHACARA Accession: BC015...: 604495, GeneID: 4793 Lot Number: MM9511...
Biology Products: